Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan

NCT00720096 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Funds for this project have been spent, and it is thereby terminated.

Conditions

Ovarian Cancer

Interventions

DRUG: Liposomal Doxorubicin
DRUG: Topotecan

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]